Ohr Pharmaceutical reports fiscal year 2017 financial results
Ohr Pharmaceutical reported a net loss of $23.8 million, or ($0.53) per share i nFY 2017, versus a net loss of $25.8 million, or ($0.82) per share, in 2016. At Sept.30, 2017, the Company had cash and cash equivalents of approximately $12.8 million. December 15, 2017